Research dossier

AHK-Cu — copper tripeptide follicular dossier

The copper analogue of GHK, studied specifically on follicular models.

6 min read · Purpeptide Research Desk ·

Translated from the French original, which remains the reference version: lire en français →

AHK-Cu — research dossier illustration

Molecular identity

ParameterValue
CAS number682809-81-0
Molar mass451.39 g/mol
Molecular formulaC₁₅H₂₄ClCuN₆O₄
Sequence / natureAla-His-Lys (chelated to Cu²⁺)
Purity≥99%
AppearanceWhite lyophilised powder

The values above correspond to the catalogue lot and are reproduced as they stand from the product page. Any discrepancy between this dossier and the product page should be reported before use.

Research context

This compound is studied mainly in comparison with GHK-Cu, which is its closest structural point of contrast. That proximity makes it a useful tool for examining the contribution of the N-terminal residue to the activity observed — a structure-activity question more than an applied one.

Mechanism studied

AHK-Cu is an alanyl-L-histidyl-L-lysine tripeptide complexed to copper(II), structurally close to GHK-Cu from which it differs at the N-terminal residue — an alanine in place of the glycine.

That substitution alters the steric crowding near the coordination site without abolishing copper binding, which is still carried by the imidazole of the histidine. The literature treats the two tripeptides as distinct entities, with gene expression profiles that overlap only partially.

The published in-vitro work on this compound deals mainly with cultures of follicular dermal papilla cells, in which VEGF (vascular endothelial growth factor) expression has been measured by ELISA and RT-qPCR. VEGF is studied in this context as a marker of peri-follicular vascularisation.

In-vitro literature

The body of work is narrower than that for GHK-Cu and rests on a limited number of groups. Direct comparisons between the two tripeptides at equivalent copper concentration remain rare — a methodological limit to keep in mind when interpreting results.

Bibliographic entry points

These links are an entry point into the literature, not an edited selection. None of the sources cited relates to a human use of this material, and consulting them directly is recommended for any protocol design.

Distinguishing this compound from its analogues

Differs from GHK-Cu by a single N-terminal residue. The two compounds are frequently confused in secondary sources; the CAS number is the reliable identifier.

The CAS number shown on the product page is the identifier to rely on. Trade names, development codes and customary abbreviations vary from one source to another and are not a reliable identification.

Methodological limits

The same limit as for GHK-Cu regarding free copper, compounded by a narrower body of work and rarer independent replication. Direct AHK-Cu / GHK-Cu comparisons at equimolar copper are few, which makes it difficult to attribute any specificity to the tripeptide itself.

These limits are not formalities: they determine what a protocol using this material can and cannot establish. Making them explicit in the experimental plan avoids attributing to the compound an observation that belongs to the measurement system.

Analytical parameters

The same remark as for GHK-Cu: the colour reflects complexation, not purity. The analyses are performed on the peptide fraction after separation.

ParameterValue
StorageStore at −20 °C, protected from light
SolubilitySoluble in bacteriostatic water (BAC)
StabilityStable for 24 months at −20 °C; 30 days after reconstitution at 2–8 °C
Control methodsRP-HPLC · MS · NMR

Reconstitution is a matter for the experimental protocol. The volume of solvent determines the final concentration and is not prescribed here: it depends on the design of the experiment and the conditions of the assay.

Resulting concentrations

The table below is arithmetic: it gives the concentration obtained for a given solvent volume, with no recommendation of use.

Format1 ml2 ml3 ml
100mg100.00 mg/ml50.00 mg/ml33.33 mg/ml

These values assume complete dissolution and a peptide content consistent with the lot report. Where the actual quantitative content differs from the nominal mass — a common discrepancy, caused by counter-ions and residual water — the effective concentration is lower than the theoretical value. That is precisely why quantitative content per vial forms part of the verification protocol.

Protocol design

Three points govern the validity of an assay using this material, whatever the question being asked.

The effective concentration is not the nominal concentration. It depends on the actual peptide content of the lot, on complete dissolution and on adsorption to the walls of the container. A concentration check after reconstitution is preferable to assuming a perfect yield.

The actual exposure time may be shorter than the nominal duration where the compound is degraded by the medium. Verify stability under the exact conditions of the assay — medium, serum, temperature, duration — before interpreting an absence of effect.

The control arm must correspond to the vehicle actually used, at the same final concentration. This requirement is unremarkable and remains the most frequent cause of irreproducible results.

Lot verification

The following formats are covered by a Janoshik Analytical report, readable from the product page:

  • 100mg — lot report available
FormatLot reportAvailability
100mgCoveredIn stock

The verification programme covers exclusively the identity and purity of the material, by reversed-phase chromatography and mass spectrometry. It covers neither sterility, nor endotoxins, nor any microbiological characteristic.

Frequently asked questions

How does this product arrive?

As a lyophilised powder in a sealed vial, shipped in insulated, plain packaging. Return the vial to the storage temperature given in the specifications on receipt.

Which solvent should be used for reconstitution?

Bacteriostatic water is the usual reconstitution solvent for lyophilised peptides in a laboratory setting. The volume is a matter for the experimental protocol and the concentration sought; we provide no dosage recommendation.

How long does the material remain stable?

The stability window appears in the specifications table on this page, before and after reconstitution. Those values correspond to the storage conditions stated; any temperature variation shortens them.

Does the analysis report correspond exactly to my vial?

The report linked on this page corresponds to the format selected. Each report is issued by Janoshik Analytical from an anonymously submitted sample, and covers the identity and purity of the peptide.

Can this product be used on humans or animals?

No. It is an analytical grade reference material intended exclusively for in-vitro laboratory research. Any administration to humans or animals is excluded, and no therapeutic, diagnostic or medical claim is made.

See also: Copper peptides: GHK-Cu, AHK-Cu and Snap-8 compared

Dossiers in the same category

Related dossiers

All research dossiers → · Catalogue → · Glossary →